HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duerr, A. Articles by Sobel, J. D. Search for Related Content PubMed PubMed Citation Articles by Duerr, A. Articles by Sobel, J. D.

Incident and Persistent Vulvovaginal Candidiasis Among Human Immunodeficiency Virus–Infected Women: Risk Factors and Severity

From the Centers for Disease Control and Prevention, Atlanta, Georgia; National Institute for Child Health and Human Development, Bethesda, Maryland; Brown University, Providence, Rhode Island; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York; Johns Hopkins University, Baltimore, Maryland; and Wayne State University, Detroit, Michigan.

Address reprint requests to: Ann Duerr, MD, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, HIV Section, Mailstop K-34, 4770 Buford Highway NE, Atlanta, GA 30341-3717; E-mail: aduerr{at}cdc.gov.

OBJECTIVE: To examine risk factors for vulvovaginal candidiasis among women with or at risk for human immunodeficiency virus (HIV) infection.

METHODS: Data were from 856 HIV-infected women and 421 at-risk uninfected women observed semiannually at four study sites from April 1993 through February 1999. At enrollment women were 15–55 years old and had no acquired immunodeficiency syndrome–defining conditions. Three definitions for vulvovaginal candidiasis of differing severity were constructed using data from vaginal Candida culture and Gram stains scored for yeast and three signs on pelvic examination (vulvovaginal edema, erythema, or discharge): 1) culture or Gram stain positivity plus at least one clinical sign, 2) culture or Gram stain positivity plus at least two clinical signs, and 3) visible yeast on Gram stain plus at least one clinical sign.

RESULTS: The prevalence and cumulative incidence of each definition of vulvovaginal candidiasis were greater among HIV-infected women than among women not infected with HIV (P < .01 for all comparisons). Stratified by status at the preceding visit, vulvovaginal candidiasis was most likely among women with prior vulvovaginal candidiasis, least likely among women without earlier Candida colonization, and intermediately likely among women with preceding subclinical Candida colonization. Among HIV-infected women, lower CD4 count and higher HIV viral load were associated with vulvovaginal candidiasis. Several other factors were independently associated with vulvovaginal candidiasis, with strong associations for diabetes mellitus and pregnancy in particular. Vulvovaginal candidiasis was not more severe among HIV-infected women.

CONCLUSION: Vulvovaginal candidiasis occurred with higher incidence and greater persistence, but not greater severity, among HIV-infected women.

This article has been cited by other articles:

				L. Myer, L. Denny, M. de Souza, T. C. Wright Jr., and L. Kuhn Distinguishing the Temporal Association between Women's Intravaginal Practices and Risk of Human Immunodeficiency Virus Infection: A Prospective Study of South African Women Am. J. Epidemiol., March 15, 2006; 163(6): 552 - 560. [Abstract] [Full Text] [PDF]